Dyne Therapeutics, Inc. (DYN)

Last Closing Price: 16.03 (2026-11-19)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Dyne Therapeutics, Inc. (DYN) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-193.55M
Cost of Goods Sold
--
--
$197.07M
$-197.07M
$3.52M
$-193.55M
$-193.55M
$-193.55M
$-193.55M
$-193.55M
$-193.55M
$-197.07M
$-196.66M
181.77M
181.77M
$-1.06
$-1.06
Balance Sheet Financials
$1.18B
$7.14M
$58.77M
$1.23B
$90.55M
$200.01M
$213.32M
$303.87M
$930.93M
$930.93M
$930.93M
187.33M
Cash Flow Statement Financials
$-452.70M
$-8.48M
$483.28M
$895.74M
$917.84M
$22.10M
$44.26M
--
--
Fundamental Metrics & Ratios
12.99
--
--
0.18
0.24
--
--
--
--
--
--
$-456.44M
--
--
--
--
--
--
--
-20.79%
-20.79%
-15.67%
-17.11%
$4.97
$-2.51
$-2.49